Insider · CIK 0001763511

Elsbernd Brian

Reports to the SEC for 1 company · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001763511

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−148K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−127K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−243K sh	$31.50	−$7.64M	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−132K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−200K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−135K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−29.8K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−10.3K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−7,067 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−98.7K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−69K sh	—	—	0
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+6,667 sh	—	—	245,124
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,667 sh	—	—	956,142
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Legal Officer	FTax Payment	−2,623 sh	—	—	242,501
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Legal Officer	FTax Payment	−2,780 sh	—	—	238,457
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−7,067 sh	—	—	962,809
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+7,067 sh	—	—	241,237
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Legal Officer	FTax Payment	−2,030 sh	—	—	234,170
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,161 sh	—	—	236,200
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,161 sh	—	—	969,876
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Legal Officer	AAward	+98.7K sh	—	—	945,161
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Legal Officer	AAward	+29.8K sh	—	—	975,037
2025-11-12	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	+40K sh	$22.70	+$908K	231,039
2025-09-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−112K sh	—	—	846,609
2025-09-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+112K sh	$2.24	+$252K	301,039
2025-09-08	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−30K sh	$20.30	−$609K	271,039
2025-09-04	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+30K sh	$2.24	+$67.2K	218,564
2025-09-04	CPRXCATALYST PHARMACEUTICALS, INC. · Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−30K sh	—	—	959,084
2025-09-04	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−30K sh	$19.52	−$586K	188,564
2025-09-03	CPRXCATALYST PHARMACEUTICALS, INC. · Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−20K sh	—	—	989,084
2025-09-03	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+20K sh	$2.24	+$44.8K	208,564
2025-09-03	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−20K sh	$20.08	−$402K	188,564
2025-03-03	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+53.3K sh	$2.24	+$119K	241,819
2025-03-03	CPRXCATALYST PHARMACEUTICALS, INC. · Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−9,270 sh	—	—	1,062,339
2025-03-03	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−9,720 sh	$23.23	−$226K	188,564
2025-03-03	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+9,270 sh	$2.24	+$20.8K	197,834
2025-03-03	CPRXCATALYST PHARMACEUTICALS, INC. · Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−53.3K sh	—	—	1,009,084
2025-03-03	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−53.3K sh	$22.93	−$1.22M	188,564
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−9,667 sh	—	—	1,071,609
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Legal Officer	FTax Payment	−2,353 sh	—	—	188,564
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+9,667 sh	—	—	190,917
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+6,667 sh	—	—	183,191
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Legal Officer	FTax Payment	−1,941 sh	—	—	181,250
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,667 sh	—	—	1,081,276
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Legal Officer	FTax Payment	−1,720 sh	—	—	176,524
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+7,067 sh	—	—	178,244
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−7,067 sh	—	—	1,087,943
2024-11-26	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+50.2K sh	$4.01	+$201K	174,677
2024-11-26	CPRXCATALYST PHARMACEUTICALS, INC. · Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−9,756 sh	—	—	1,095,010
2024-11-26	CPRXCATALYST PHARMACEUTICALS, INC. · Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−50.2K sh	—	—	1,104,766

Recent filings

Accepted (ET)
Jul 174
Elsbernd Brian0001161697-26-000176
SEC(opens sec.gov)
Dec 304
Elsbernd Brian0001161697-25-000491
SEC(opens sec.gov)
Dec 104
Elsbernd Brian0001161697-25-000445
SEC(opens sec.gov)
Nov 244
Elsbernd Brian0001161697-25-000416
SEC(opens sec.gov)

Companies

CATALYST PHARMACEUTICALS, INC.Chief Legal OfficerCPRX

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134